Zoekresultaten - 17 results
Contextual factors influencing the equitable implementation of precision medicine in routine cancer care in Belgium
centre Manuscript versions: DOI: https://doi.org/10.1093/eurpub/ckae055 File: Version: Published Full text access: Public Access Full text language: English Category: Peer-reviewed scientific ...
Linkage of individual-patient data confirm protection of prophylactic human papillomavirus vaccination against invasive cervical cancer
Publication Type: Peer reviewed scientific article Authors: M. Arbyn; P. Rousta; Bruni, Laia; Schollin Ask, Lina; Basu, Partha Source: JNCI: Journal of the National Cancer Institute (2024) Keywords: ...
Clinical performance of the novel full-genotyping OncoPredict HPV Quantitative Typing assay using the VALGENT framework.
reproducibility of the assay was assessed on a subpopulation, comprising 526 samples. The relative sensitivity and specificity for OncoPredict HPV QT vs GP5 +/6+- PCR- EIA were 1.01 (95% CI: 0.99-1.03) and 1.03 ...
Can REALQUALITY RQ-HPV screen be considered as a clinically validated HPV test for use in cervical cancer screening?
Publication Type: Peer reviewed scientific article Authors: M. Arbyn; Cuschieri, Kate; Poljak, Mario; Bonde, Jesper Source: Clin Microbiol Infect, Volume 29, Issue 12 (2023) Keywords: Early ...
HPV-based Cervical Cancer Screening on Self-samples in the Netherlands: Challenges to Reach Women and Test Performance Questions.
self-sampling (16% in 2020). HPV positivity and detection rate of precancer (CIN3 +) were lower in the self-sampling compared with the clinician-sampling group (adjusted OR s of 0.65 and 0.86, respectively). ...
Do genomic passports leave us more vulnerable or less vulnerable? Perspectives from an online citizen engagement
Publication Type: Peer reviewed scientific article Authors: Chloé Mayeur; Mertes, Heidi; Wannes Van Hoof Source: Humanities and Social Sciences Communications, Volume 10, Issue 1 (2023) Keywords: ...
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT‐2 framework
index versus comparator were 1.01 (95% confidence interval [CI]: 0.99-1.03) and 1.02 (95% CI: 1.0-1.04), respectively. Noninferiority p values were all ≤0.05, except for CIN3 + in patients ≥30 years. ...
Accuracy of high-risk HPV DNA PCR, p16(INK4a) immunohistochemistry or the combination of both to diagnose HPV-driven oropharyngeal cancer
Martin; Vanderveken, Olivier; Kumar, Rekha Vijay; Gangane, Nitin; Caniglia, Alessandro; Maffini, Fausto; Lloveras Rubio, Maria Belén; Anantharaman, Devasena; Chiocca, Susanna; Brennan, Paul; Pillai, ...
HPV DNA genotyping, HPV E6*I mRNA detection, and p16INK4a/Ki-67 staining in Belgian head and neck cancer patient specimens, collected within the HPV-AHEAD study
Martin; Vanderveken, Olivier; Kumar, Rekha Vijay; Gangane, Nitin; Caniglia, Alessandro; Maffini, Fausto; Lloveras Rubio, Maria Belén; Anantharaman, Devasena; Chiocca, Susanna; Brennan, Paul; Pillai, ...
Roadbook for the implementation of next-generation sequencing in clinical practice in oncology and hemato-oncology in Belgium.
Doren; Anouk Waeytens; Marc Van den Bulcke Source: Arch Public Health, Volume 76 (2018) Abstract: In the field of oncology research, next-generation sequencing has contributed significantly to the ...